Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jianjie Li
Optimal First‐line Treatment for Advanced Thymic Carcinoma
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Related publications
Angiogenesis Genotyping in the Selection of First-Line Treatment With Either Sunitinib or Pazopanib for Advanced Renal Cell Carcinoma
Oncotarget
Oncology
PCN10 Targeted Therapy (TT) for First Line Treatment of Advanced Renal Cell Carcinoma (RCC): An Indirect Comparison Meta-Analysis (ICMA)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy
Clinical Genitourinary Cancer
Oncology
Urology
Lenalidomide as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Exploration of Biomarkers for Treatment Efficacy
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
First-Line Vascular Endothelial Growth Factor Inhibitors for Advanced Renal Cell Carcinoma and the Impact of New Agents Entering the Treatment Paradigm
BJU International
Urology
Cost-Effectiveness Analysis of Sunitinib Versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore
International Journal of Technology Assessment in Health Care
Health Policy
Redefining Treatment Paradigms in First-Line Advanced Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Emerging Treatment Options for Patients With Recurrent Advanced Thymic Epithelial Tumors
OncoTargets and Therapy
Oncology
Pharmacology
Pcn190 - Cost-Effectiveness of Nivolumab + Ipilimumab in First-Line Treatment of Advanced or Metastatic Renal Cell Carcinoma in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
